{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:19:52Z","timestamp":1778555992946,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejphar.2020.173385","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T20:50:01Z","timestamp":1595451001000},"page":"173385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Demonstration of an action pathway in mouse platelets leading to prolongation of bleeding time by fluoxetine"],"prefix":"10.1016","volume":"883","author":[{"given":"Ru","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cairu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeman","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173385_bib1","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1177\/106002809202601205","article-title":"Abnormal platelet aggregation associated with fluoxetine therapy","volume":"26","author":"Alderman","year":"1992","journal-title":"Ann. Pharmacother."},{"issue":"Suppl. 2","key":"10.1016\/j.ejphar.2020.173385_bib2","first-page":"123","article-title":"Mechanism of action of antidepressants","volume":"36","author":"Artigas","year":"2002","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ejphar.2020.173385_bib3","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1038\/sj.npp.1301355","article-title":"Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study","volume":"32","author":"Atar","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2020.173385_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/bip.22679","article-title":"Regulation of integrins in platelets","volume":"104","author":"Bennett","year":"2015","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejphar.2020.173385_bib5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","article-title":"The Expanded biology of serotonin","volume":"60","author":"Berger","year":"2009","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2020.173385_bib6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.RES.0000143899.73453.11","article-title":"Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo","volume":"95","author":"Bergmeier","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2020.173385_bib7","first-page":"14","article-title":"Fluoxetine and hemostatic function: a pilot study","volume":"56","author":"Berk","year":"1995","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173385_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2011.08.013","article-title":"Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs","volume":"136","author":"Bismuth-Evenzal","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2020.173385_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004714-200204000-00005","article-title":"Serotonin and fluoxetine levels in plasma and platelets after fluoxetine treatment in depressive patients","volume":"22","author":"Blardi","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173385_bib10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1365-2141.1996.d01-1485.x","article-title":"A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140\/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation","volume":"92","author":"Boukerche","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2020.173385_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000544","article-title":"Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants","volume":"2","author":"Castro","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.ejphar.2020.173385_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/archinte.163.1.59","article-title":"Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study","volume":"163","author":"Dalton","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2020.173385_bib13","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1538-7836.2009.03476.x","article-title":"Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17)","volume":"7","author":"Duerschmied","year":"2009","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2020.173385_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.31887\/DCNS.2007.9.1\/dhalperin","article-title":"Influence of antidepressants on hemostasis","volume":"9","author":"Halperin","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173385_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1389200023338017","article-title":"Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update","volume":"3","author":"Hemeryck","year":"2002","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejphar.2020.173385_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1067\/mcp.2000.110456","article-title":"Paroxetine decreases platelet serotonin storage and platelet function in human beings","volume":"68","author":"Hergovich","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2020.173385_bib17","first-page":"727","article-title":"VandenBerg SR. Fluoxetine and the bleeding time","volume":"114","author":"Humphries","year":"1990","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.ejphar.2020.173385_bib18","first-page":"605","article-title":"Selective serotonin re-uptake inhibitors: an overview","volume":"30","author":"Joshi","year":"2018","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.ejphar.2020.173385_bib19","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A dual thrombin receptor system for platelet activation","volume":"394","author":"Kahn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173385_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1037\/pha0000264","article-title":"The effect of selective serotonin reuptake inhibitors in healthy subjects revisited: a systematic review of the literature","volume":"27","author":"Knorr","year":"2019","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.ejphar.2020.173385_bib21","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/ijms18081803","article-title":"Platelet aggregometry testing: molecular mechanisms, techniques and clinical implications","volume":"18","author":"Koltai","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.ejphar.2020.173385_bib22","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/(SICI)1099-1557(199808)7:1+<S54::AID-PDS345>3.0.CO;2-Z","article-title":"Study of haemostasis in depressive patients treated with fluoxetine","volume":"7","author":"Lain\u00e9-Cessac","year":"1998","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2020.173385_bib23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4088\/JCP.v62n0210g","article-title":"Antidepressant treatment and global tests of coagulation and fibrinolysis","volume":"62","author":"Lederbogen","year":"2001","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173385_bib24","first-page":"14","article-title":"Fluoxetine: clinical pharmacology and physiologic disposition","volume":"46","author":"Lemberger","year":"1985","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173385_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/pds.1546","article-title":"Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity","volume":"17","author":"Lewis","year":"2008","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2020.173385_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00001721-199711000-00006","article-title":"Effects of serotonin on platelet activation in whole blood","volume":"8","author":"Li","year":"1997","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.ejphar.2020.173385_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jad.2015.08.025","article-title":"Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants","volume":"187","author":"Li","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2020.173385_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jad.2014.02.022","article-title":"Prothrombotic platelet phenotype in major depression: downregulation by antidepressant treatment","volume":"159","author":"Lopez-Vilchez","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.ejphar.2020.173385_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/hrp\/7.2.69","article-title":"Selective serotonin-reuptake inhibitors: an update","volume":"7","author":"Masand","year":"1999","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.ejphar.2020.173385_bib30","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1538-7836.2007.02690.x","article-title":"Proteomic analysis of platelet alpha-granules using mass spectrometry","volume":"5","author":"Maynard","year":"2007","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2020.173385_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(99)00015-8","article-title":"Platelet dense granules: structure, function and implications for haemostasis","volume":"95","author":"McNicol","year":"1999","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2020.173385_bib32","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1161\/01.CIR.102.16.1931","article-title":"P-selectin expression on platelets determines size and stability of platelet aggregates","volume":"102","author":"Merten","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2020.173385_bib33","first-page":"320","article-title":"Ecchymosis associated with the use of fluoxetine: case report","volume":"13","author":"Mirsal","year":"2002","journal-title":"T\u00fcrk Psikiyatri Derg."},{"key":"10.1016\/j.ejphar.2020.173385_bib34","doi-asserted-by":"crossref","first-page":"20210","DOI":"10.1074\/jbc.M116.736983","article-title":"Loss of serotonin transporter function alters ADP-mediated glycoprotein \u03b1IIb\u03b23 activation through dysregulation of the 5-HT2A receptor","volume":"291","author":"Oliver","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2020.173385_bib35","first-page":"259","article-title":"Risk of hemorrhage with the use of fluoxetine (Prozac) or fluvoxamine (Fevarin)","volume":"137","author":"Ottervanger","year":"1993","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"10.1016\/j.ejphar.2020.173385_bib36","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/106002809603000716","article-title":"Bruising associated with the use of fluoxetine","volume":"30","author":"Pai","year":"1996","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2020.173385_bib37","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.clinthera.2019.06.008","article-title":"Postpartum bleeding in pregnant women receiving SSRIs\/SNRIs: new insights from a descriptive observational study and an analysis of data from the FAERS database","volume":"41","author":"Perrotta","year":"2019","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173385_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004714-200004000-00004","article-title":"Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment","volume":"20","author":"Pollock","year":"2000","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173385_bib39","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2020.173385_bib40","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/JCP.0000000000000575","article-title":"Selective serotonin reuptake inhibitors and operative bleeding risk: a review of the literature","volume":"36","author":"Roose","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173385_bib41","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1038\/s41598-018-21348-3","article-title":"Citalopram inhibits platelet function independently of SERT-mediated 5-HT transport","volume":"8","author":"Roweth","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2020.173385_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor","volume":"84","author":"Savage","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173385_bib43","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1388-9842(03)00005-9","article-title":"Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin","volume":"5","author":"Serebruany","year":"2003","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2020.173385_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/2045125311423781","article-title":"SSRI-induced coagulopathy: is it reality","volume":"1","author":"Siddiqui","year":"2011","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2020.173385_bib45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.thromres.2010.09.017","article-title":"A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation","volume":"126","author":"Tseng","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2020.173385_bib46","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/ALN.0b013e3181cf8fdf","article-title":"Use of serotonergic antidepressants and bleeding risk in orthopedic patients","volume":"112","author":"van Haelst","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2020.173385_bib48","first-page":"445","article-title":"SSRI-induced bleeding: two case reports","volume":"56","author":"Vandel","year":"2001","journal-title":"Therapie"},{"key":"10.1016\/j.ejphar.2020.173385_bib49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0092-8674(03)01014-6","article-title":"Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release","volume":"115","author":"Walther","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173385_bib50","first-page":"102","article-title":"Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding","volume":"119","author":"Yuet","year":"2019","journal-title":"J. Am. Osteopath. Assoc."},{"issue":"9","key":"10.1016\/j.ejphar.2020.173385_bib51","article-title":"Intelligent classification of platelet aggregates by agonist type","volume":"12","author":"Zhou","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.ejphar.2020.173385_bib52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2018.07.033","article-title":"Platelet serotonin and serotonin transporter as peripheral surrogates in depression and anxiety patients","volume":"834","author":"Zhuang","year":"2018","journal-title":"Eur. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920304775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920304775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:42:58Z","timestamp":1757976178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920304775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":51,"alternative-id":["S0014299920304775"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173385","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Demonstration of an action pathway in mouse platelets leading to prolongation of bleeding time by fluoxetine","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"173385"}}